Type 2 Diabetes
‘All of us need to be vigilant’: Steps to combat growing NAFLD, NASH epidemic
The incidence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis continues to rise with obesity and type 2 diabetes, and all clinicians must screen patients at high cardiometabolic risk, according to a speaker.
‘Cultural competence’ key to reduce cardiometabolic risk among South Asian subgroups
South Asian adults develop cardiovascular disease approximately a decade earlier than people of other ethnicities, and the multifactorial causes of premature risk show more preventive work is needed, according to a speaker.
Human, exendin-based GLP-1 receptor agonists similarly reduce CV, renal risk in diabetes
A pooled study assessing trials of eight GLP-1 receptor agonists showed all reduce risk for a combined endpoint of major adverse cardiovascular events, regardless of structural homology to human GLP-1, as well as individual CV components.
Intermittent very low-calorie diet lowers glucose levels in adults with obesity, diabetes
Adults with obesity and type 2 diabetes improved glucose levels after eating a very low-calorie diet either 2 or 4 days per week, according to study findings published in the Journal of Diabetes Investigation.
Eat less fat, more fiber and vitamin C to reduce CVD risk in diabetes
Adults newly diagnosed with type 2 diabetes had a lower long-term risk for cardiovascular disease if they had lower fat intake and higher intake of fiber and vitamin C, according to data published in Diabetic Medicine.
‘Remission’ best term to define return of normal glucose levels in type 2 diabetes
The term “remission” should be used to describe a person with type 2 diabetes who has achieved a disease-free status, according to a consensus report.
Maintaining normal weight may lower diabetes likelihood for adults with high genetic risk
People at high genetic risk are more likely to develop type 2 diabetes at some point in their lifetime, but maintaining normal weight may mitigate the increased risk, according to a study published in Diabetic Medicine.
Longer diabetes duration lowers likelihood for meeting glycemic targets
People with a longer duration of diabetes are less likely to achieve glycemic targets, according to a study published in Journal of Diabetes and Its Complications.
HbA1c poor marker for all-cause mortality in adults with high glycemic variability
HbA1c may not be a robust marker for all-cause mortality among adults with type 2 diabetes and a high degree of glycemic variability, suggesting new metrics assessing glycemic response are needed.
Prevalence of diabetes in youth increased significantly since 2001
The estimated prevalence of type 1 and type 2 diabetes increased significantly among children and adolescents in the U.S. from 2001 to 2017, according to findings published in JAMA.